Document is current
Any future updates will be listed below
-
Authors
Lindsay, Kevin E.
Bhosle, Sushma M.
Zurla, Chiara
Beyersdorf, Jared https://orcid.org/0000-0002-6997-4175
Rogers, Kenneth A.
Vanover, Daryll
Xiao, Peng
Araínga, Mariluz
Shirreff, Lisa M.
Pitard, Bruno
Baumhof, Patrick
Villinger, Francois
Santangelo, Philip J. https://orcid.org/0000-0001-7352-0339
- License Information
-
More Information
Article History
Received: 14 May 2018
Accepted: 28 February 2019
First Online: 1 April 2019
Competing interests
: B.P. owns stock in In-Cell-Art, which commercializes lipidic aminoglycoside derivatives. P.B. is an employee at CureVac, which commercializes RNA-based vaccines.
